Results 171 to 180 of about 283,736 (263)

Chronic hepatitis C and the risk for atherosclerotic and cardiomyopathic heart disease. [PDF]

World J Hepatol
Elkhattib I, Raafat KW, Elsayed B, Elnaggar M.   +3 more
europepmc   +1 more source

Renal Function in Chronic Hepatitis C Patients in Mongolia. [PDF]

Diagnostics (Basel)
Dashjamts G, Ganzorig AE, Tsedendorj Y, Batsaikhan A, Daramjav D, Khayankhyarvaa E, Ulziitsogt B, Nergui O, Davaasuren NE, Dondov G, Badamjav T, Lonjid T, Huang CF, Lin TC, Batsaikhan B, Dai CY.   +15 more
europepmc   +1 more source

Calcium Intake and Bone Mineral Density in People With HIV and/or Chronic Hepatitis C. [PDF]

Open Forum Infect Dis
Temesgen ZB, Temesgen Z, Bedimo RJ.
europepmc   +1 more source

Evaluating long-term outcomes of direct-acting antiviral therapy in chronic hepatitis C: A retrospective study. [PDF]

Medicine (Baltimore)
Sung BR, Shim SG, Kim KM, Lee JW, Kim JY, Lee BK, Jun CH, Kwan BS.   +7 more
europepmc   +1 more source

Sex-related differences in treatment outcomes of chronic hepatitis C with direct-acting antivirals. [PDF]

World J Hepatol
Feyissa GD.
europepmc   +1 more source

Risk of drug-induced liver injury in chronic hepatitis C and tuberculosis co- infection: a systematic review and meta- analysis. [PDF]

BMC Infect Dis
Wei X, Cai R, Wu X, Su Y, Lian S, Nan T, Ye X, Wei J.   +7 more
europepmc   +1 more source

Fibrotic, metabolic and clinical improvements in patients with chronic hepatitis C treated with direct-acting antiviral therapy in a resource limited setting: a prospective cohort study. [PDF]

BMC Gastroenterol
Ekubazgi KW, Dellil M, Woldegeorgis BZ, Berhane KA, Anagaw S, Fisseha H.   +5 more
europepmc   +1 more source

Real-world Effectiveness and Safety of Coblopasvir plus Sofosbuvir in the Treatment of Chronic Hepatitis C Infection in Wenzhou, Eastern China: A Multicenter Observational Study. [PDF]

J Clin Transl Hepatol
Ruan LM, Zhang XC, Zhang XY, Zhou QQ, Zheng QN, Fu CL, Hu YB, Zhou Y, Wu YH.   +8 more
europepmc   +1 more source

Aspartate aminotransferase-to-platelet ratio index (APRI) for staging of fibrosis in adults with chronic hepatitis C. [PDF]

Cochrane Database Syst Rev
Dreytser E, Blyuss O, Mudrova A, Turankova T, Gurusamy KS, Pavlov CS.   +5 more
europepmc   +1 more source